UBS Group Lowers Stevanato Group (NYSE:STVN) Price Target to $23.50

Stevanato Group (NYSE:STVN) had its target price lowered by analysts at UBS Group from $24.00 to $23.50 in a report issued on Friday,Benzinga reports. The firm currently has a “neutral” rating on the stock.

Several other equities analysts have also recently weighed in on STVN. Bank of America raised their price target on Stevanato Group from $24.00 to $26.00 and gave the company a “buy” rating in a report on Friday, December 13th. Morgan Stanley reiterated an “equal weight” rating and issued a $23.00 target price (down previously from $24.00) on shares of Stevanato Group in a report on Tuesday, December 3rd. Finally, Wolfe Research started coverage on Stevanato Group in a report on Friday, December 13th. They issued an “outperform” rating and a $28.00 target price for the company. Two equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of €27.75 ($30.16).

Stevanato Group Stock Performance

NYSE:STVN opened at €21.72 ($23.61) on Friday. The company has a current ratio of 1.81, a quick ratio of 1.21 and a debt-to-equity ratio of 0.22. Stevanato Group has a 12-month low of €16.56 ($18.00) and a 12-month high of €33.49 ($36.40). The stock has a 50-day moving average price of €21.38 and a 200 day moving average price of €20.54. The stock has a market capitalization of $6.58 billion, a P/E ratio of 46.21, a P/E/G ratio of 7.18 and a beta of 0.60.

Stevanato Group (NYSE:STVN) last released its earnings results on Thursday, March 6th. The company reported €0.20 ($0.22) earnings per share (EPS) for the quarter, hitting the consensus estimate of €0.20 ($0.22). Stevanato Group had a return on equity of 9.86% and a net margin of 10.47%. The firm had revenue of €352.68 million during the quarter, compared to analysts’ expectations of €346.26 million. Equities research analysts forecast that Stevanato Group will post 0.5 EPS for the current fiscal year.

Institutional Investors Weigh In On Stevanato Group

Institutional investors and hedge funds have recently modified their holdings of the business. Van Berkom & Associates Inc. bought a new stake in shares of Stevanato Group during the 4th quarter worth approximately $39,000. Johnson Financial Group Inc. bought a new stake in shares of Stevanato Group during the 4th quarter worth approximately $41,000. Wells Fargo & Company MN lifted its stake in shares of Stevanato Group by 680.3% during the 4th quarter. Wells Fargo & Company MN now owns 3,246 shares of the company’s stock worth $71,000 after acquiring an additional 2,830 shares during the last quarter. PNC Financial Services Group Inc. lifted its stake in shares of Stevanato Group by 1,457.6% during the 4th quarter. PNC Financial Services Group Inc. now owns 5,654 shares of the company’s stock worth $123,000 after acquiring an additional 5,291 shares during the last quarter. Finally, Tower Research Capital LLC TRC lifted its stake in shares of Stevanato Group by 202.8% during the 4th quarter. Tower Research Capital LLC TRC now owns 7,413 shares of the company’s stock worth $162,000 after acquiring an additional 4,965 shares during the last quarter.

Stevanato Group Company Profile

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.